QSAM Biosciences, Inc.

QSAM · OTC
Analyze with AI
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Activities
Net Income-$4-$5-$12-$5
Dep. & Amort.$36,300$0$0$1,250
Deferred Tax$142,604$0$0-$1,250
Stock-Based Comp.$1$2$9$0
Change in WC-$0$1$0$0
Other Non-Cash-$178,904-$0$1$4
Operating Cash Flow-$3-$3-$2-$1
Investing Activities
PP&E Inv.$0$0$0$0
Net Acquisitions$0$0$0$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$0$0$0$0
Investing Cash Flow$0$0$0$0
Financing Activities
Debt Repay.$0$0$1$0
Stock Issued$4$1$2,221,000$100,000
Stock Repurch.$0$0-$2,191,462-$64,560
Dividends Paid$0$0$0$0
Other Fin. Act.$4$1$3$1
Financing Cash Flow$4$1$3$1
Forex Effect$0$0$0$0
Net Chg. in Cash$1-$1$1$0
Supplemental Information
Beg. Cash$0$1$0$0
End Cash$1$0$1$0
Free Cash Flow-$3-$3-$2-$1